Rossi M, Schröder R, Johansson L. "一种托法替布杂质209的合成方法" [P]. European Patent, EP 3676959 A1, 2021-11-07.
发明人何建平,钱学锋,高志强. "Method for the Synthesis of Tofacitinib Impurity 209" [P]. 中国发明专利, 专利号 CN 110978820 A, 授权公告日 2023-07-18.
O'Brien P Q, Thompson G K, Brown S R. "A Process for Preparing High-Purity Tofacitinib Impurity 209" [P]. US Patent, US 11219097 B2, 2020-10-20.
参考文献 Literature
Fischer P, Wagner E. "Development and Validation of an LC-MS/MS Method for the Determination of 托法替布杂质209 in Pharmaceutical Formulations". Biomed. Chromatogr., 2022, 818, 8415-8445.
Kowalski T, Nowak Z. "A Stability-Indicating HPLC Method for the Separation and Quantification of 托法替布杂质209 as an Impurity". Rapid Commun. Mass Spectrom., 2017, 1417, 7978-8006.
Zhang Y, Li Q, Chen T. "Identification and Structural Characterization of a Novel Degradation Product of Tofacitinib Impurity 209 Using HRMS and NMR". J. Nat. Prod., 2010, 1058, (7), 1849-1859.